Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Coty Inc. Class A Common Stock (NY:COTY)

4.120 -0.040 (-0.96%)
Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Coty Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Q4 Earnings Highs And Lows: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers. 
Via StockStory
Topics Economy
3 Stocks Under $10 in Hot Water
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
Forecasting The Future: 13 Analyst Projections For Coty
 
Via Benzinga
3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
Beauty stocks are off to an ugly start in 2025, but there may be 1 stock that will lead the rebound as they already beat and raised earnings guidance. 
Via MarketBeat
These Analysts Cut Their Forecasts On Coty After Downbeat Earnings
 
Via Benzinga
The Analyst Verdict: Coty In The Eyes Of 7 Experts
 
Via Benzinga
The Analyst Verdict: Coty In The Eyes Of 8 Experts
 
Via Benzinga
Demystifying Coty: Insights From 18 Analyst Reviews
 
Via Benzinga
Coty Provides Update on Category Leadership, Financial Progress, and Strategy to Fuel Outperformance of Beauty Market at CAGNY 2025 Conference
From Coty
Via Business Wire
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter
 
Via Benzinga
Kris Jenner Puts Her 'Keeping Up With The Kardashian' Mansion On the Market For $13.5 Million. Here's A Look At Her Property Portfolio
 
Via Benzinga
Coty Faces Challenges As Category Weakness Lies Ahead, Say Analysts
Stifel analyst Mark S. Astrachan lowered Coty's price target from $8.5 to $8, maintaining a Hold rating. Despite adjusted EBITDA growth, Coty's second-quarter FY25 results revealed a 1% YoY decline in... 
Via Benzinga
Coty Stock In Spotlight As Q2 Earnings Miss Estimates, But Retail’s Optimistic
Sentiment on Stocktwits improved to ‘bullish’ from ‘bearish’ a week ago. 
Via Stocktwits
Topics Earnings
Peeling Back The Layers: Exploring Coty Through Analyst Insights
 
Via Benzinga
Coty (NYSE:COTY) Misses Q4 Revenue Estimates
Beauty products company Coty (NYSE:COTY) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $1.67 billion. Its non-GAAP profit of $0.11 per share was... 
Via StockStory
Topics Economy
Coty Reports Solid 1H25 Financial Performance, With Strong Margin Expansion and Cash Generation in an Uncertain Market Environment
From Coty
Via Business Wire
Coty Stock Falls Ahead of Q2 Earnings: Retail Sentiment Downbeat
Sentiment on Stocktwits worsened to ‘bearish’ from ‘neutral’ one week ago. 
Via Stocktwits
Coty (COTY) Reports Q4: Everything You Need To Know Ahead Of Earnings
Beauty products company Coty (NYSE:COTY) will be announcing earnings results tomorrow after the bell. Here’s what you need to know. 
Via StockStory
Coty (COTY): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Coty. The stock has dropped 31.4% and now trades at $6.83, rattling many shareholders. This was partly due to its softer quarterly results and may have investors... 
Via StockStory
Earnings Scheduled For February 10, 2025
 
Via Benzinga
1 Consumer Stock to Hold Forever and 2 to Dump
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs, but the sector has bucked this trend... 
Via StockStory
Topics Stocks
Rebalancing in 2025: Here Are 3 Stocks to Buy Under $10
If you're looking to rebalance your portfolio in 2025, here are three stocks trading for under $10 per share to consider buying 
Via MarketBeat
Elf Beauty Vs. Coty: Which Beauty Stock To Buy — 'Disruptive' Player Or 'Strong Transformation Story'?
Beauty category's convergence with wellness segment increases market for players. Goldman Sachs analyst evaluates 2 beauty stocks. 
Via Benzinga
Coty and Swarovski Sign Long-Term Agreement for New Entry Into Beauty Market
From Coty
Via Business Wire
Coty Inc. Announces Early Results of its Cash Tender Offer for a Portion of its Outstanding 5.000% Senior Secured Notes due 2026
From Coty
Via Business Wire
Personal Care Stocks Q3 Teardown: Herbalife (NYSE:HLF) Vs The Rest
Looking back on personal care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Herbalife (NYSE:HLF) and its peers. 
Via StockStory
Topics Economy
Personal Care Stocks Q3 Highlights: Coty (NYSE:COTY)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Coty... 
Via StockStory
Topics Economy
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 9
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 4-8, 2024. 
Via Talk Markets
This Ford Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
 
Via Benzinga
Coty (NYSE:COTY) Reports Q3 In Line With Expectations
Beauty products company Coty (NYSE:COTY) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 1.8% year on year to $1.67 billion. Its non-GAAP profit of $0.15 per share was 18.3% below... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.